2019
DOI: 10.1021/acsomega.9b00929
|View full text |Cite
|
Sign up to set email alerts
|

Identification of New Mono/Dihydroxynaphthoquinone as Lead Agents That Inhibit the Growth of Refractive and Triple-Negative Breast Cancer Cell Lines

Abstract: Human epidermal growth factor receptor 2 (HER2) is overexpressed in nearly 20–30% of breast cancers and is associated with metastasis resulting in poor patient survival and high recurrence. The dual EGFR/HER2 kinase inhibitor lapatinib has shown promising clinical results, but its limitations have also led to the resistance and activation of tumor survival pathways. Following our previous investigation of quinones as HER2 kinase inhibitors, we synthesized several naphthoquinone derivatives that significantly i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 50 publications
(105 reference statements)
0
1
0
Order By: Relevance
“…Furthermore, it was shown that cytotoxic chemotherapy can reduce the expression rate or suppress the HER2 gene (Shu et al 2018 ). In a study which was reported by Schroeder et al ( 2019 ), it was shown that HER2 gene expression was inhibited by naphthoquinones (Schroeder et al 2019 ). In this study, we found that the HER2 gene was significantly down-regulated in AGS cell line treatment group when exposed to the 0.8 mg ml −1 dose concentration after 24 h of incubation.…”
Section: Discussionmentioning
confidence: 97%
“…Furthermore, it was shown that cytotoxic chemotherapy can reduce the expression rate or suppress the HER2 gene (Shu et al 2018 ). In a study which was reported by Schroeder et al ( 2019 ), it was shown that HER2 gene expression was inhibited by naphthoquinones (Schroeder et al 2019 ). In this study, we found that the HER2 gene was significantly down-regulated in AGS cell line treatment group when exposed to the 0.8 mg ml −1 dose concentration after 24 h of incubation.…”
Section: Discussionmentioning
confidence: 97%